183 related articles for article (PubMed ID: 24356791)
1. Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
Cupisti K; Lehwald N; Anlauf M; Riemer J; Werner TA; Krieg A; Witte J; Chanab A; Baldus SE; Krausch M; Raffel A; Herdter C; Schott M; Knoefel WT
Horm Metab Res; 2014 Feb; 46(2):138-44. PubMed ID: 24356791
[TBL] [Abstract][Full Text] [Related]
2. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
3. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
5. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis in thyroid papillary microcarcinoma: a study of 170 patients.
Varshney R; Pakdaman MN; Sands N; Hier MP; Rochon L; Black MJ; Payne RJ
J Laryngol Otol; 2014 Oct; 128(10):922-5. PubMed ID: 25226511
[TBL] [Abstract][Full Text] [Related]
7. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Ardito G; Revelli L; Giustozzi E; Salvatori M; Fadda G; Ardito F; Avenia N; Ferretti A; Rampin L; Chondrogiannis S; Colletti PM; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):25-8. PubMed ID: 23242040
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Papillary Microtumor: Validation of the (Updated) Porto Proposal Assessing Sex Hormone Receptor Expression and Mutational BRAF Gene Status.
Aliyev E; Ladra-González MJ; Sánchez-Ares M; Abdulkader-Nallib I; Piso-Neira M; Rodríguez-Carnero G; Vieiro-Balo P; Pérez-Becerra R; Gude-Sampedro F; Barreiro-Morandeira F; Alvarez CV; Cameselle-Teijeiro JM
Am J Surg Pathol; 2020 Sep; 44(9):1161-1172. PubMed ID: 32804453
[TBL] [Abstract][Full Text] [Related]
9. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
10. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
11. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
12. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
13. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
[TBL] [Abstract][Full Text] [Related]
14. [Papillary thyroid microcarcinomas: review of 230 cases].
Bozec A; Peyrottes I; Poissonnet G; Chamorey E; Mahdyoun P; Sudaka A; Ettore F; Benisvy D; Bussière F; Marcy PY; Vallicioni J; Demard F; José S; Dassonville O
Rev Laryngol Otol Rhinol (Bord); 2009; 130(4-5):215-20. PubMed ID: 20597400
[TBL] [Abstract][Full Text] [Related]
15. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.
Kim J; Giuliano AE; Turner RR; Gaffney RE; Umetani N; Kitago M; Elashoff D; Hoon DS
Ann Surg; 2006 Nov; 244(5):799-804. PubMed ID: 17060774
[TBL] [Abstract][Full Text] [Related]
17. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
18. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype.
Falvo L; D'Ercole C; Sorrenti S; D'Andrea V; Catania A; Berni A; Grilli P; De Antoni E
Eur J Surg Suppl; 2003 Jul; (588):28-32. PubMed ID: 15200040
[TBL] [Abstract][Full Text] [Related]
19. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
20. [Clinical picture of differentiated thyroid carcinoma in the T1 stage].
Czarniecka A; Włoch J; Lange D
Wiad Lek; 2001; 54 Suppl 1():225-33. PubMed ID: 12182030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
